Literature DB >> 24591939

The correlation of the antral follicle count and Serum anti-mullerian hormone.

Behiye Pınar Göksedef1, Nurettin Idiş1, Hüsnü Görgen1, Yaprak Rüstemoğlu Asma1, Murat Api1, Ahmet Cetin1.   

Abstract

OBJECTIVE: To compare the value of the basal serum anti-Müllerian hormone (AMH) level with most of the established ovarian reserve tests.
MATERIAL AND METHODS: A total of 141 infertile women was studied prospectively. On cycle day 3, serum levels of AMH, inhibin B, estradiol (E), FSH and LH levels were measured, and the number of early antral follicles (2-6 mm in diameter) estimated at ultrasound scanning to compare the strengths of hormonal-follicular correlations.
RESULTS: The mean age of the participants was 29.18±5.54. The mean AMH and total AFC on day 3 were 2.23±1.90 ng/ml and 8.35±2.83, respectively. Serum AMH levels were more tightly correlated (p<0.001) with number of the early antral follicle count (r=0.467, p<0.0001) than age and serum levels of FSH (r=-0.400, p<0.001; r=-0.299, p<0.001 respectively). No correlation was detected between serum levels of inhibin B, E2, and LH (r=0.154, p=0.06; p=0.31; r=-0.085 and r=0.067, p=0.42) and AFC.
CONCLUSION: Serum AMH levels showed a strong correlation with AFC, and also this correlation is stronger than the other ovarian reserve parameters.

Entities:  

Keywords:  Anti-mullerian hormone; antral follicle count; ovarian reserve

Year:  2010        PMID: 24591939      PMCID: PMC3939154          DOI: 10.5152/jtgga.2010.40

Source DB:  PubMed          Journal:  J Turk Ger Gynecol Assoc        ISSN: 1309-0380


  28 in total

1.  The number of antral follicles in normal women with proven fertility is the best reflection of reproductive age.

Authors:  G J Scheffer; F J M Broekmans; C W N Looman; M Blankenstein; B C J M Fauser; F H teJong; E R teVelde
Journal:  Hum Reprod       Date:  2003-04       Impact factor: 6.918

2.  Anti-Müllerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation.

Authors:  Wouter J K Hehenkamp; Caspar W N Looman; Axel P N Themmen; Frank H de Jong; E R Te Velde; Frank J M Broekmans
Journal:  J Clin Endocrinol Metab       Date:  2006-06-27       Impact factor: 5.958

Review 3.  [Antral follicle count and oocyte quality].

Authors:  C Avril
Journal:  J Gynecol Obstet Biol Reprod (Paris)       Date:  2006-09

Review 4.  Developmental and endocrine aspects of normal ovarian aging.

Authors:  E R te Velde; G J Scheffer; M Dorland; F J Broekmans; B C Fauser
Journal:  Mol Cell Endocrinol       Date:  1998-10-25       Impact factor: 4.102

5.  Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH?

Authors:  R Nahum; J L Shifren; Y Chang; L Leykin; K Isaacson; T L Toth
Journal:  J Assist Reprod Genet       Date:  2001-03       Impact factor: 3.412

6.  Early follicular antimüllerian hormone as an indicator of ovarian reserve.

Authors:  Cem Fiçicioglu; Tayfun Kutlu; Elif Baglam; Zeynep Bakacak
Journal:  Fertil Steril       Date:  2006-03       Impact factor: 7.329

7.  Anti-Müllerian hormone inhibits initiation of primordial follicle growth in the mouse ovary.

Authors:  Alexandra L L Durlinger; Maria J G Gruijters; Piet Kramer; Bas Karels; Holly A Ingraham; Mark W Nachtigal; Jan Th J Uilenbroek; J Anton Grootegoed; Axel P N Themmen
Journal:  Endocrinology       Date:  2002-03       Impact factor: 4.736

8.  Mullerian inhibiting substance levels at the time of HCG administration in IVF cycles predict both ovarian reserve and embryo morphology.

Authors:  T Silberstein; D T MacLaughlin; I Shai; J R Trimarchi; G Lambert-Messerlian; D B Seifer; D L Keefe; A S Blazar
Journal:  Hum Reprod       Date:  2005-08-25       Impact factor: 6.918

9.  Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment.

Authors:  Christien Weenen; Joop S E Laven; Anne R M Von Bergh; Mark Cranfield; Nigel P Groome; Jenny A Visser; Piet Kramer; Bart C J M Fauser; Axel P N Themmen
Journal:  Mol Hum Reprod       Date:  2004-02       Impact factor: 4.025

10.  Anti-müllerian hormone is a promising predictor for the occurrence of the menopausal transition.

Authors:  Ilse A J van Rooij; Isolde den Tonkelaar; Frank J M Broekmans; Caspar W N Looman; Gabrielle J Scheffer; Frank H de Jong; Axel P N Themmen; Egbert R te Velde
Journal:  Menopause       Date:  2004 Nov-Dec       Impact factor: 2.953

View more
  6 in total

Review 1.  Ovarian aging and premature ovarian failure.

Authors:  Yavuz Emre Sükür; Içten Balık Kıvançlı; Batuhan Ozmen
Journal:  J Turk Ger Gynecol Assoc       Date:  2014-08-08

2.  Serum and follicular fluid Anti-Mullerian hormone concentrations at the time of follicle puncture and reproductive outcome.

Authors:  Selma İnat Capkın; Sebnem Ozyer; Rana Karayalçın; Ozlem Moraloğlu; Sarp Ozcan; Mustafa Uğur
Journal:  J Turk Ger Gynecol Assoc       Date:  2012-03-01

3.  The correlations of anti-mullerian hormone, follicle-stimulating hormone and antral follicle count in different age groups of infertile women.

Authors:  Ludmila Barbakadze; Jenara Kristesashvili; Natalia Khonelidze; Gia Tsagareishvili
Journal:  Int J Fertil Steril       Date:  2015-02-07

4.  Follicle Stimulating Hormone and Anti-Müllerian Hormone among Fertile and Infertile Women in Ile-Ife, Nigeria: Is there A Difference?

Authors:  Temitope Okunola; Kayode Olusegun Ajenifuja; Olabisi Morebise Loto; Afolabi Salawu; Stephen Oluseyi Omitinde
Journal:  Int J Fertil Steril       Date:  2016-11-11

5.  Evaluation of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio and Red Blood Cell Distribution Width-Platelet Ratio for Diagnosis of Premature Ovarian Insufficiency.

Authors:  Gulsah Ilhan; Fatma Ferda Verit Atmaca; Esra Altan; Ali Galip Zebitay; Hamdullah Sozen; Hurkan Akyol; Meryem Kurek Eken
Journal:  J Family Reprod Health       Date:  2016-12

6.  Anti-Mullerian Hormone as a Marker of Ovarian Reserve and Function.

Authors:  Sudwita Sinha; Amrita Sharan; Sangeeta Sinha
Journal:  Cureus       Date:  2022-09-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.